Yiming Liu represents companies and investment funds on strategic transactions in the life sciences and technology industries. Yiming regularly advises clients on the structuring, negotiation and documentation of a wide range of cross-border transactions, including mergers and acquisitions, private equity financings, joint ventures, research collaborations and licensing arrangements. In addition, Yiming is widely recognized for his work on life sciences IPOs in Hong Kong and the US.

Download full bio 


  • Keymed Biosciences – HK$3.1 Billion IPO 


  • Columbia University

  • University of Michigan
    MS (molecular, cellular, and developmental biology) , MHSA (health services administration)

  • Fudan University
    BS (biological sciences)

Admissions & Credentials

New York